Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Journal of the American Medical Association
Biotech
FDA advisers tear apart case for Biogen's aducanumab
The JAMA article restates the case against aducanumab ahead of a June decision by the FDA on whether to approve the closely watched medicine.
Nick Paul Taylor
Apr 1, 2021 7:45am
Cancer trials a major victim of pandemic: JAMA
Feb 9, 2021 7:35am
FDA de novo pathway clearing devices without enough evidence
Oct 23, 2020 9:15am
FDA under fire over accelerated approval data demands
Aug 16, 2017 8:45am